Patricia L. Harris

Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib

Thomas J. Lynch, Daphne W. Bell, Raffaella Sordella et al. · New England Journal of Medicine · 2004 · 11.5K citations

Medicine, Oncology, Pharmacology +16

Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib

Eunice L. Kwak, Raffaella Sordella, Daphne W. Bell et al. · Proceedings of the National Academy of Sciences · 2005 · 952 citations

Medicine, Medicinal Chemistry, Pharmacology +13

Epidermal Growth Factor Receptor Mutations and Gene Amplification in Non–Small-Cell Lung Cancer: Molecular Analysis of the IDEAL/INTACT Gefitinib Trials

Daphne W. Bell, Thomas J. Lynch, Sara M. Haserlat et al. · Journal of Clinical Oncology · 2005 · 607 citations

Medicine, Molecular Genetics, Oncology +17

Epidermal Growth Factor Receptor Kinase Domain Mutations in Esophageal and Pancreatic Adenocarcinomas

Eunice L. Kwak, Janusz Jankowski, Sarah P. Thayer et al. · Clinical Cancer Research · 2006 · 158 citations · Full text

Medicine, Molecular Medicine, Oncology +15

Response of Some Head and Neck Cancers to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors May Be Linked to Mutation of<i>ERBB2</i>rather than<i>EGFR</i>

Ezra E.W. Cohen, Mark W. Lingen, Leslie E. Martin et al. · Clinical Cancer Research · 2005 · 129 citations

Medicine, Oncology, Pharmacology +15